Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study.
Breban M, Vignon E, Claudepierre P, Devauchelle V, Wendling D, Lespessailles E, Euller-Ziegler L, Sibilia J, Perdriger A, Mezières M, Alexandre C, Dougados M.
Breban M, et al. Among authors: wendling d.
Rheumatology (Oxford). 2002 Nov;41(11):1280-5. doi: 10.1093/rheumatology/41.11.1280.
Rheumatology (Oxford). 2002.
PMID: 12422001
Clinical Trial.